• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of tobcontTobacco ControlVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Tob Control. Sep 2001; 10(3): 218–224.
PMCID: PMC1747585

Policy makers' perspectives on tobacco control advocates' roles in regulation development


OBJECTIVE—To identify, from policy makers' perspectives, strategies that enhance tobacco control advocates' effectiveness in the regulatory arena.
DESIGN—Key informant interview component of a comparative case study of regulatory agencies in the USA.
SUBJECTS—Policy makers involved in the development of four regulatory tobacco control policies (three state and one federal).
METHODS—Interviews of policy makers, field notes, and deliberation minutes were coded inductively.
RESULTS—Policy makers considered both written commentary and public testimony when developing tobacco control regulations. They triaged written commentary based upon whether the document was from a peer reviewed journal, a summary of research evidence, or from a source considered credible. They coped with in-person testimony by avoiding being diverted from the scientific evidence, and by assessing the presenters' credibility. Policy makers suggested that tobacco control advocates should: present science in a format that is well organised and easily absorbed; engage scientific experts to participate in the regulatory process; and lobby to support the tobacco control efforts of the regulatory agency.
CONCLUSIONS—There is an important role for tobacco control advocates in the policy development process in regulatory agencies.

Keywords: health policy; regulations; policy makers

Full Text

The Full Text of this article is available as a PDF (127K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Glantz SA, Parmley WW. Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation. 1991 Jan;83(1):1–12. [PubMed]
  • Steenland K. Passive smoking and the risk of heart disease. JAMA. 1992 Jan 1;267(1):94–99. [PubMed]
  • Borland R, Chapman S, Owen N, Hill D. Effects of workplace smoking bans on cigarette consumption. Am J Public Health. 1990 Feb;80(2):178–180. [PMC free article] [PubMed]
  • Glasgow RE. Assessment of smoking behavior in relation to worksite smoking policies. N Y State J Med. 1989 Jan;89(1):31–34. [PubMed]
  • Woodruff TJ, Rosbrook B, Pierce J, Glantz SA. Lower levels of cigarette consumption found in smoke-free workplaces in California. Arch Intern Med. 1993 Jun 28;153(12):1485–1493. [PubMed]
  • Pierce JP, Gilpin EA, Emery SL, White MM, Rosbrook B, Berry CC, Farkas AJ. Has the California tobacco control program reduced smoking? JAMA. 1998 Sep 9;280(10):893–899. [PubMed]
  • Wakefield MA, Chaloupka FJ, Kaufman NJ, Orleans CT, Barker DC, Ruel EE. Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ. 2000 Aug 5;321(7257):333–337. [PMC free article] [PubMed]
  • Farkas AJ, Gilpin EA, White MM, Pierce JP. Association between household and workplace smoking restrictions and adolescent smoking. JAMA. 2000 Aug 9;284(6):717–722. [PubMed]
  • Bero LA, Galbraith A, Rennie D. Sponsored symposia on environmental tobacco smoke. JAMA. 1994 Feb 23;271(8):612–617. [PubMed]
  • Barnes DE, Bero LA. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996 Fall;21(3):515–542. [PubMed]
  • Arno PS, Brandt AM, Gostin LO, Morgan J. Tobacco industry strategies to oppose federal regulation. JAMA. 1996 Apr 24;275(16):1258–1262. [PubMed]
  • Aneshensel CS, Frerichs RR, Clark VA, Yokopenic PA. Telephone versus in-person surveys of community health status. Am J Public Health. 1982 Sep;72(9):1017–1021. [PMC free article] [PubMed]
  • Colombotos J. Personal versus telephone interviews: effect on responses. Public Health Rep. 1969 Sep;84(9):773–782. [PMC free article] [PubMed]
  • Bero LA, Jadad AR. How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med. 1997 Jul 1;127(1):37–42. [PubMed]
  • Bero L, Barnes DE, Hanauer P, Slade J, Glantz SA. Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents. JAMA. 1995 Jul 19;274(3):241–247. [PubMed]
  • Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998 May 20;279(19):1566–1570. [PubMed]
  • Barnes DE, Bero LA. Scientific quality of original research articles on environmental tobacco smoke. Tob Control. 1997 Spring;6(1):19–26. [PMC free article] [PubMed]
  • Turner C, Spilich GJ. Research into smoking or nicotine and human cognitive performance: does the source of funding make a difference? Addiction. 1997 Nov;92(11):1423–1426. [PubMed]
  • Cohen JE, Goldstein AO, Flynn BS, Munger MC, Gottlieb NH, Solomon LJ, Dana GS. State legislators' perceptions of lobbyists and lobbying on tobacco control issues. Tob Control. 1997 Winter;6(4):332–336. [PMC free article] [PubMed]

Articles from Tobacco Control are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...